# Biological Effects of Quercetin in COPD

> **NCT03989271** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Temple University** · enrollment: 29 (estimated)

## Conditions studied

- Chronic Obstructive Pulmonary Disease

## Interventions

- **DRUG:** Quercetin

## Key facts

- **NCT ID:** NCT03989271
- **Lead sponsor:** Temple University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-10-01
- **Primary completion:** 2024-05-30
- **Final completion:** 2025-07-01
- **Target enrollment:** 29 (ESTIMATED)
- **Last updated:** 2023-08-16

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03989271

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03989271, "Biological Effects of Quercetin in COPD". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03989271. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
